Dr. Joshua J. Chalkley, DO, MS

Dr. Chalkley practices at University of Kentucky Albert B. Chandler Hospital in Lexington, Kentucky, part of University of Kentucky HealthCare.

Dr. Chalkley's NPI, 1043368491, was assigned on January 8, 2007. Dr. Chalkley holds Kentucky license 03951.

Dr. Chalkley's primary practice is University of Kentucky Albert B. Chandler Hospital, at 800 Rose Street, Lexington, KY 40536 in Fayette County. The practice phone is (859) 257-2278.

Dr. Chalkley's primary practice is University of Kentucky Albert B. Chandler Hospital in Lexington, Kentucky, part of University of Kentucky HealthCare. The medical group on file is University of Kentucky General Pediatrics. Dmand AI also links Dr. Chalkley to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chalkley practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Chalkley's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Chalkley is licensed in Kentucky.

CMS data shows 183 Medicare services from Dr. Chalkley across 4 procedure codes in 2024, all of them office visits, for 122 Medicare patients. Medicare paid $14,760 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 122 Medicare patients who saw Dr. Chalkley in 2024. The largest group is under 65, with 59 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 39% are also on Medicaid. Their average risk score is 1.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chalkley's median patient age at 57, with 69% women.

In 2024, Dr. Chalkley wrote 2,138 Medicare Part D claims for 258 patients. 78% of them were for generic drugs. CMS names the drug for 1,782 of them, across 41 drugs with 11 or more claims each, at $2,516,970 in total drug cost. In 2023, CMS named 1,533 claims across 35 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Chalkley for performance year 2024, reported as part of a group. Dr. Chalkley accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chalkley as offering telehealth.

Dmand AI links 4 papers to Dr. Chalkley, published from 2014 to 2021. The most frequent topics are Multiple Sclerosis, Aquaporin 4 and Neuromyelitis Optica. Dr. Chalkley has published most often in Mult Scler Relat Disord. Dr. Chalkley's most frequent co-authors are Joseph Rossi Berger, MD, Padmaja Sudhakar, MD and Khawla M. Abusamra, MD.

CMS Open Payments shows 172 general payments to Dr. Chalkley from 24 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 70% of the total. Biogen, Inc. paid the most, $12,331.